Lv1
40 积分 2024-03-27 加入
The current and emerging immunotherapy paradigm in small-cell lung cancer
6小时前
待确认
Improved Antitumor Efficacy of a Dextran-based Docetaxel-coupled Conjugate against Triple-Negative Breast Cancer
3个月前
已完结
Strategies and challenges for the next generation of antibody–drug conjugates
4个月前
已完结
Biopharmaceutics of Paclitaxel (Taxol): Formulation, Activity, and Pharmacokinetics
5个月前
已关闭
Biopharmaceutics of Paclitaxel (Taxol): Formulation, Activity, and Pharmacokinetics
5个月前
已关闭
Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact
5个月前
已完结
Nanotechnology for immuno-oncology
5个月前
已完结
皖公网安备34019202002308
